• Mashup Score: 2

    Topic: European Society of Cardiology Session type: Hot Line Date: 28 August Start time: 14:00 End time: 15:20 Location: Amsterdam Chairpersons Shelley Zieroth (University of Manitoba – Winnipeg, Canada) ShelleyZieroth Jose Ramon Gonzalez Juanatey (University Hospital of Santiago de Compostela – Santiago de Compostela, Spain) JoseJuanateyPresentationsRED-CVD: Improving early diagnosis of…

    Tweet Tweets with this article
    • One week left until #Hotline results of #PUSHAHF during #ESCcongress2023 ! #natriuresis guided #diuretic therapy in acute #heartfailure https://t.co/cbCg7aN1oj @jozinetm @CardiologyUmcg @iebeldhuis @WilfriedMullens @PieterMartensMD @FH_Verbrugge

  • Mashup Score: 0
    Heart Failure 2023 - 12 month(s) ago

    Late breaking clinical trials: chronic HF and cardiomyopathies Topic: Treatment Session type: Late-Breaking Science Date: 20 May Start time: 16:00 End time: 17:00 Location: Room 1 Chairpersons Frank Ruschitzka (University Heart Center – Zurich, Switzerland) Petar Seferovic (University Clinical Center of Serbia – Belgrade, Serbia) PresentationsRemote Hemodynamic Monitoring of Pulmonary…

    Tweet Tweets with this article
    • Less than a week away until #HeartFailure2023 ! Excitement guaranteed. Looking forward to #MONITORHF study, presented by Dr Brugts on Cardiomems cost effectiveness in the Netherlands https://t.co/fh4OSD66DA 1/4

  • Mashup Score: 0
    Heart Failure 2023 - 12 month(s) ago

    Late breaking clinical trials: acute heart failure and patients’ monitoring Topic: Chronic Heart Failure Session type: Late-Breaking Science Date: 22 May Start time: 11:15 End time: 12:15 Location: Room 1 Chairpersons Ovidiu Chioncel (Institute of Cardiovascular Diseases Prof. C.C. Iliescu – Bucharest, Romania) Joann Lindenfeld (Vanderbilt University – Nashville, United States of America) …

    Tweet Tweets with this article
    • Furthermore @JeroenDauw will present the first important piece of the puzzle in effectiveness of #natriuresis guided acute #heartfailure treatment. He will present data of #ENACT https://t.co/NjANzh7t4q. This is the first of multiple important trials on this subject! 2/4

  • Mashup Score: 0

    Background Left ventricular assist device (LVAD) therapy is an established treatment for advanced heart failure with reduced ejection fraction. We evaluated the characteristics and clinical outcomes of patients implanted with an LVAD in the Netherlands. Methods Patients implanted with an LVAD in the Netherlands between 2016 and 2020 were included in the analysis. Baseline characteristics entered…

    Tweet Tweets with this article
    • #LVAD implantation in the Netherlands: outcome of this much needed therapy in a country with low number of transplant and long waiting list times (up to 5 years). Also destination therapy (DT) outcome data from reimbursement in 2015. https://t.co/bIEwCjwWKQ